Avadel Pharmaceuticals plc ADR buy BiotechBee
Start price
17.07.23
/
70%
€13.60
Target price
31.12.25
€23.00
Performance (%)
11.03%
End price
14.12.24
-
Summary
This prediction is currently being closed. The prediction currently has a performance of 11.03%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Avadel Pharmaceuticals plc ADR | - | - | - | - |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
According to BiotechBee what are the pros and cons of Avadel Pharmaceuticals plc ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Avadel Pharmaceuticals plc ADR diskutieren
Buy mit Kursziel 23,0
In the thread Trading Avadel Pharmaceuticals plc ADR
Buy beendet

